Literature DB >> 3858382

Biosynthetic relationships of the chondroitin sulfate proteoglycan with Ia and invariant chain glycoproteins.

A J Sant, S E Cullen, B D Schwartz.   

Abstract

As a first step to elucidating the role of the Ia-associated chondroitin sulfate proteoglycan (CSPG) in the biology of the Ia antigens, we have studied several aspects of the interactions of the CSPG with the Ia/invariant chain glycoproteins. These studies revealed that at any time point, only 2 to 5% of Ia molecules were associated with the CSPG, and that this fraction included Ia molecules that were expressed at the cell surface. Pulse-chase studies indicated that the association of Ia molecules and the CSPG was rapid and short lived. Newly synthesized [35S]sulfate-labeled CSPG molecules were detected in association with Ia molecules immediately after a 15-min pulse, but were barely detectable after a 30-min chase, and were completely undetectable after a 60-min chase. Similarly, newly synthesized [3H]leucine-labeled Ia molecules associated with the CSPG were detectable immediately after a 20-min pulse, and after a 75-min chase, but could not be detected in association with the CSPG after a 300-min chase. Virtually no CSPG that was similar in size to that associated with Ia molecules was found free in the cells or was secreted into the media. The results in this report are compatible with the hypothesis that some or all of the Ia molecules associate transiently with the CSPG, or that a small fraction of Ia molecules associate permanently with the CSPG in a short-lived complex. These studies tend to favor a role for the CSPG in the biosynthesis of Ia rather than in intracellular trafficking or in intercellular communication.

Entities:  

Mesh:

Substances:

Year:  1985        PMID: 3858382

Source DB:  PubMed          Journal:  J Immunol        ISSN: 0022-1767            Impact factor:   5.422


  15 in total

1.  A retroviral mutagenesis screen identifies Cd74 as a common insertion site in murine B-lymphomas and reveals the existence of a novel IFNgamma-inducible Cd74 isoform.

Authors:  Magdalena Pyrz; Bruce Wang; Matthias Wabl; Finn Skou Pedersen
Journal:  Mol Cancer       Date:  2010-04-23       Impact factor: 27.401

2.  Involvement of two classes of binding sites in the interactions of cyclophilin B with peripheral blood T-lymphocytes.

Authors:  A Denys; F Allain; M Carpentier; G Spik
Journal:  Biochem J       Date:  1998-12-15       Impact factor: 3.857

3.  Identification of the glycosaminoglycan-attachment site of mouse invariant-chain proteoglycan core protein by site-directed mutagenesis.

Authors:  J Miller; J A Hatch; S Simonis; S E Cullen
Journal:  Proc Natl Acad Sci U S A       Date:  1988-03       Impact factor: 11.205

4.  Murine T lymphocytes and T-lymphoma cells produce chondroitin sulphate and heparan sulphate proteoglycans and free heparan sulphate glycosaminoglycan.

Authors:  A P Wilson; C C Rider
Journal:  Immunology       Date:  1991-01       Impact factor: 7.397

5.  Conservation of a polyanion binding site in mammalian and avian CD4.

Authors:  C R Parish; H S Warren
Journal:  Immunology       Date:  1991-10       Impact factor: 7.397

6.  Effects of cell density and extracellular matrix on the lateral diffusion of major histocompatibility antigens in cultured fibroblasts.

Authors:  M L Wier; M Edidin
Journal:  J Cell Biol       Date:  1986-07       Impact factor: 10.539

7.  Mouse B lymphocyte specific endocytosis and recycling of MHC class II molecules.

Authors:  J Salamero; M Humbert; P Cosson; J Davoust
Journal:  EMBO J       Date:  1990-11       Impact factor: 11.598

8.  Invariant chain is the core protein of the Ia-associated chondroitin sulfate proteoglycan.

Authors:  A J Sant; S E Cullen; K S Giacoletto; B D Schwartz
Journal:  J Exp Med       Date:  1985-12-01       Impact factor: 14.307

9.  Cell surface expression of class II histocompatibility antigens occurs in the absence of the invariant chain.

Authors:  R P Sekaly; C Tonnelle; M Strubin; B Mach; E O Long
Journal:  J Exp Med       Date:  1986-11-01       Impact factor: 14.307

10.  MIF signal transduction initiated by binding to CD74.

Authors:  Lin Leng; Christine N Metz; Yan Fang; Jing Xu; Seamas Donnelly; John Baugh; Thomas Delohery; Yibang Chen; Robert A Mitchell; Richard Bucala
Journal:  J Exp Med       Date:  2003-06-02       Impact factor: 14.307

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.